News

Deal Announcements

GrayBug Lands On Venture Capital Equity

Tuesday, March 10, 2015 5:46:00 AM PDT | VentureDeal
   Baltimore, Maryland  --  Medical technology company GrayBug has garnered $1.74 million in new equity financing, according to an SEC regulatory filing.

GrayBug is commercializing a proprietary controlled release system for ophthalmic pharmaceutical indications.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

GrayBug is still seeking $240,000 in additional financing, according to the filing.

The company is backed by a syndicate of venture capital and other investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1